Patents by Inventor Yuwen Zhu

Yuwen Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDER
    Publication number: 20220235136
    Abstract: The present application provides agents that specifically inhibits the IGFBP7/CD93 signaling pathway, such as agents that specifically block the interaction between CD93 and IGFBF7, methods of using said agents and methods of identifying said agents.
    Type: Application
    Filed: March 25, 2022
    Publication date: July 28, 2022
    Applicants: YALE UNIVERSITY, The Regents of the University of Colorado, a body corporate
    Inventors: Yuwen ZHU, Lieping CHEN, Richard SCHULICK, Yi SUN
  • Compositions and methods for modulating T-cell mediated immune response
    Patent number: 10407484
    Abstract: The present disclosure relates to compositions and methods for modulating T-cell mediated immune response in a subject in need thereof. The method includes administering to the subject an effective amount of a CD112R protein, a fusion polypeptide, a complex including CD112R and a second protein, or an anti-CD112R antibody of the present disclosure.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: September 10, 2019
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Yuwen Zhu, Barish H. Edil, Richard D. Schulick, Alessandro Paniccia, Michelle Koenig, Alexander C. Schulick
  • COMPOSITIONS AND METHODS FOR MODULATING T-CELL MEDIATED IMMUNE RESPONSE
    Publication number: 20170240613
    Abstract: The present disclosure relates to compositions and methods for modulating T-cell mediated immune response in a subject in need thereof. The method includes administering to the subject an effective amount of a CD112R protein, a fusion polypeptide, a complex including CD112R and a second protein, or an anti-CD112R antibody of the present disclosure.
    Type: Application
    Filed: September 2, 2016
    Publication date: August 24, 2017
    Inventors: Yuwen Zhu, Barish H. Edil, Richard D. Schulick, Alessandro Paniccia, Michelle Koenig, Alexander C. Schulick